These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease. Johnston N, Jernberg T, Lagerqvist B, Siegbahn A, Wallentin L. Int J Cardiol; 2006 Nov 10; 113(2):167-73. PubMed ID: 16338010 [Abstract] [Full Text] [Related]
3. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL. J Am Coll Cardiol; 2003 Feb 05; 41(3):360-70. PubMed ID: 12575961 [Abstract] [Full Text] [Related]
4. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques. Anselmi M, Garbin U, Agostoni P, Fusaro M, Pasini AF, Nava C, Keta D, Turri M, Zardini P, Vassanelli C, Lo Cascio V, Cominacini L. Atherosclerosis; 2006 Mar 05; 185(1):114-20. PubMed ID: 15998517 [Abstract] [Full Text] [Related]
5. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women? Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB. J Am Coll Cardiol; 2006 Sep 05; 48(5):973-9. PubMed ID: 16949489 [Abstract] [Full Text] [Related]
8. The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose. Lu C, Gao Y, Zhou H, Tian H. Coron Artery Dis; 2008 Dec 05; 19(8):565-73. PubMed ID: 19005291 [Abstract] [Full Text] [Related]
10. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score. Che J, Li G, Wang W, Li Q, Liu H, Chen K, Liu T. Cardiol J; 2011 Dec 05; 18(4):364-70. PubMed ID: 21769816 [Abstract] [Full Text] [Related]
12. Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. Maiolino G, Pedon L, Cesari M, Frigo AC, Barisa M, Rossitto G, Seccia TM, Zanchetta M, Rossi GP. Int J Cardiol; 2013 Sep 20; 168(1):484-9. PubMed ID: 23102599 [Abstract] [Full Text] [Related]
13. Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting. Braun S, Ndrepepa G, von Beckerath N, Mehilli J, Gorchakova O, Vogt W, Schömig A, Kastrati A. Am Heart J; 2005 Sep 20; 150(3):550-6. PubMed ID: 16169339 [Abstract] [Full Text] [Related]
14. Relationship of lipid oxidation with subclinical atherosclerosis and 10-year coronary events in general population. Gómez M, Vila J, Elosua R, Molina L, Bruguera J, Sala J, Masià R, Covas MI, Marrugat J, Fitó M. Atherosclerosis; 2014 Jan 20; 232(1):134-40. PubMed ID: 24401227 [Abstract] [Full Text] [Related]